BioAmber Inc.
BIOA.WS
BIOA.WS was delisted on the 3rd of May, 2017.
12 hedge funds and large institutions have $12.5M invested in BioAmber Inc. in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 9 → 12 (+3)
3% less capital invested
Capital invested by funds: $12.8M → $12.5M (-$335K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$1.04K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$782 |
| 3 |
Barclays
London,
United Kingdom
|
+$555 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20.3K |
| 2 |
SCM
Saba Capital Management
New York
|
-$4.17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WRF
1
Waddell & Reed Financial
Overland Park,
Kansas
| $7.11M | – | – | – |
|
|
ACPU
2
Arrowgrass Capital Partners (US)
Dover,
Delaware
| $2.24M | – | – | – |
|
|
PRCM
3
Pine River Capital Management
Minnetonka,
Minnesota
| $1.36M | – | – | – |
|
|
MCM
4
Moore Capital Management
New York
| $625K | – | – | – |
|
|
SFM
5
Soros Fund Management
New York
| $475K | – | – | – |
|
|
LCS
6
Levin Capital Strategies
New York
| $389K | – | – | – |
|
|
SCM
7
Saba Capital Management
New York
| $167K | -$4.17K | -1,600 | -2% |
|
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $93K | -$20.3K | -7,789 | -16% |
|
|
PWAM
9
Park West Asset Management
San Francisco,
California
| $36K | – | – | – |
|
|
GSC
10
Ground Swell Capital
Folly Beach,
South Carolina
| $1K | +$782 | +300 | New |
|
|
U
11
UBS
Zurich,
Switzerland
| $1K | +$1.04K | +400 | New |
|
|
12
Barclays
London,
United Kingdom
| – | +$555 | +213 | New |
|
BIOA.WS Hedge Fund Activity: Q3 2014 in Review
12 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA.WS) for Q3 2014, worth a combined $12.5M — down 2.6% from $12.8M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BIOA.WS positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS, opening a new position worth an estimated $1.04K. The largest seller was Deutsche Bank, cutting an estimated $20.3K.
- 12 institutional investors held BioAmber Inc. (BIOA.WS) as of Q3 2014, up from 9 in Q2 2014.
- Funds reported $12.5M of BioAmber Inc. stock for Q3 2014, down 2.6% quarter-over-quarter.
- 3 funds opened new BioAmber Inc. positions in Q3 2014 and 0 closed out, a net change of +3 holders.
- The largest BioAmber Inc. buyer in Q3 2014 was UBS, an estimated $1.04K added.
- The largest BioAmber Inc. seller in Q3 2014 was Deutsche Bank, an estimated $20.3K sold.
Based on aggregated 13F filings for Q3 2014.